Nefazodone |
Serzone |
Nefazodone Systematic (IUPAC) name 2-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one Identifiers CAS number 83366-66-9 ATC code N06AX06 PubChem 4449 DrugBank APRD00402 Chemical data Formula C25H32ClN5O2 Mol. weight 506.5 Pharmacokinetic data Bioavailability 20% (IV only) Metabolism Hepatic (active metabolites) Half life 2-4 hours Excretion 55% urine 20-30% feces Therapeutic consideratio ...
Wikipedia - [full article]
Nefazodone Clinical Trials
- Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
ClinicalTrials.gov Identifier: NCT00015210 - Active, not recruiting
Cocaine-Related Disorders; Substance-Related Disorders
- Effectiveness of Nefazodone and Bupropion in Treating Marijuana Dependent Individuals
ClinicalTrials.gov Identifier: NCT00249509 - Active, not recruiting
Marijuana Abuse
- Effect of Nefazodone on Relapse in Females with Cocaine Abuse - 10
ClinicalTrials.gov Identifier: NCT00000293 - Completed
Cocaine-Related Disorders
- Effects of Nefazodone on Treatment of Female Cocaine Abusers - 3
ClinicalTrials.gov Identifier: NCT00000286 - Completed
Cocaine-Related Disorders
- Nefazodone in the Treatment of Social Phobia
ClinicalTrials.gov Identifier: NCT00231348 - Completed
Social Anxiety Disorder (SAD)

Not Signed In -


